Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 18 Nov 22 EFFECT Notice of effectiveness
- 16 Nov 22 POS AM Prospectus update (post-effective amendment)
- 14 Feb 22 424B3 Prospectus supplement
- 7 Jan 22 424B3 Prospectus supplement
- 20 Oct 21 424B3 Prospectus supplement
- 4 Oct 21 424B3 Prospectus supplement
- 7 Apr 21 424B3 Prospectus supplement
- 19 Nov 20 424B3 Prospectus supplement
- 9 Nov 20 424B3 Prospectus supplement
- 6 Aug 20 424B3 Prospectus supplement
- 13 Jul 20 EFFECT Notice of effectiveness
- 10 Jul 20 424B3 Prospectus supplement
-
22 Jun 20 F-1 Registration statement (foreign)
MITO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement onForm F-1 of our report dated April 1, 2020, relating to the financial statements of Stealth BioTherapeutics Corp, appearing in the Annual Report onForm 20-F for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
June 22, 2020